Related by context. All words. (Click for frequent words.) 70 Immunotherapy 69 immunotherapies 69 cancer immunotherapy 69 immunotherapeutic 65 monoclonal antibody 65 antibody 63 monoclonal antibodies 63 chemotherapies 62 therapies 62 personalized immunotherapy 62 therapeutics 62 disease modifying 62 cancer immunotherapies 62 biologic therapy 61 interferon alpha 60 rituximab 60 humanized antibody 60 Nanobody 60 interferon 60 immunomodulator 60 Gefitinib 60 immunotherapeutics 60 TLR9 agonist 60 oral antiviral 60 mAbs 60 siRNA therapeutics 60 YONDELIS 60 bevacizumab Avastin ® 60 chemotherapeutic agents 59 antiviral therapies 59 therapeutic antibody 59 temozolomide 59 Rituximab 59 bevacizumab Avastin 59 ixabepilone 59 molecularly targeted 59 chemotherapeutics 59 Gleevec resistant 59 gene therapy 59 subcutaneous immunotherapy 59 virotherapy 59 OncoVEX 59 PDE4 inhibitor 59 Panzem 59 OncoVEX GM CSF 59 oncolytic 59 Abiraterone 59 anti TNF 59 antisense 59 tyrosine kinase inhibitor 59 bendamustine 59 immunomodulators 59 Intravenous CP 58 chemotherapeutic 58 MEK inhibitors 58 anticancer therapy 58 imatinib Gleevec 58 chemotherapeutic drug 58 cetuximab 58 antisense oligonucleotides 58 daclizumab 58 RhuDex ® 58 Urocidin 58 CHOP chemotherapy 58 Zolinza 58 anticancer 58 trastuzumab Herceptin 58 adjuvant 58 PEP# [003] 58 anticancer agents 58 proteasome inhibitors 58 temsirolimus 58 angiogenesis inhibitor 58 humanized antibodies 58 Tarvacin 58 TREANDA 58 Traficet EN 58 anticancer drugs 58 alpha interferon 58 novel peptide 58 Alocrest 58 IAP inhibitors 58 Amrubicin 58 PARP inhibitors 58 investigational monoclonal antibody 58 docetaxel 58 DXL# 58 sublingual immunotherapy 58 biologic therapies 58 Ceflatonin 58 paclitaxel Taxol 58 Interferon alpha 58 Allovectin 7 57 Altastaph 57 BiovaxID 57 Factor VIIa 57 antibodies 57 milatuzumab 57 IVIg 57 rituximab Rituxan 57 CD# antibody [001] 57 bortezomib Velcade 57 immunomodulatory 57 tyrosine kinase inhibitors 57 goserelin 57 azacitidine 57 siRNA delivery 57 zileuton 57 immunotoxins 57 decitabine 57 proteasome inhibitor 57 alkylating agent 57 anticancer therapies 57 Gleevec imatinib mesylate 57 MyVax R 57 siRNA 57 relapsed ovarian cancer 57 prophylactic vaccine 57 cilengitide 57 taxanes 57 therapeutic regimens 57 radionuclide therapy 57 superficial bladder cancer 57 chemotherapeutic agent 57 nanoviricide 57 intradermal injection 57 PI3K inhibitors 57 nanoviricides 57 GRNVAC1 57 Irinotecan 57 therapeutic monoclonal antibodies 57 DCVax Brain 57 RNAi therapeutic 57 Erbitux cetuximab 57 lapatinib Tykerb 57 TKIs 57 anti CD# antibodies 57 eniluracil 57 Onconase 57 CYT# QbG# 57 immunosuppressant 57 5 FU 57 MAb 57 targeted antifolate 57 multi kinase inhibitor 57 ISF# 57 pomalidomide 57 multitargeted 57 BiTE 57 lupus nephritis 57 monoclonal antibody therapies 57 biotherapy 57 nucleoside analogues 57 Advexin 56 PEGylated 56 enzastaurin 56 abiraterone 56 DCVax R 56 vaccine 56 CBLC# 56 liposomal 56 ganetespib 56 IRX 2 56 PKC# 56 BCR ABL inhibitors 56 CEQ# 56 abiraterone acetate 56 Rituxan 56 immunotherapeutic agent 56 oncolytic virus 56 antiviral therapy 56 Kinoid 56 oncolytic viruses 56 immunotherapeutic vaccine 56 vascular disrupting agents 56 neuroprotection 56 EndoTAG 56 therapeutic antibodies 56 Proxinium TM 56 Revimmune 56 mTOR inhibitors 56 DCVax 56 atacicept 56 BRAF inhibitor 56 Radilex 56 Interferon 56 thalidomide Thalomid 56 vorinostat 56 cyclosporin 56 VitiGam 56 Nanobody ® 56 IMA# 56 erlotinib Tarceva 56 sorafenib Nexavar 56 antifungal therapy 56 Sym# 56 DermaVir Patch 56 carboplatin paclitaxel 56 TELINTRA 56 JAK inhibitors 56 peptide antigens 56 olaparib 56 Sorafenib 56 beta interferon 56 Torisel 56 liposomal doxorubicin 56 Velcade bortezomib 56 GVAX 56 TG# [001] 56 Trastuzumab 56 angiogenesis inhibitors 56 VEGF inhibitors 56 imatinib 56 Azedra 56 Doxil 56 DermaVir 56 immune modulatory 56 obatoclax 56 immune modulating 56 humanized anti 56 intranasal delivery 56 dendritic cell 56 GeoVax vaccine 56 Dasatinib 56 ACZ# 56 immune modulation 56 small molecule 56 parthenolide 56 HuMax CD4 56 investigational therapies 56 Gemcitabine 56 antiviral 56 Scancell 56 gemcitabine 56 immunoconjugate 56 Allovectin 7 ® 56 CYC# 56 Marqibo 56 forodesine 56 anti CD3 antibody 56 Tolamba 56 bortezomib 56 CTLA4 Ig 56 therapeutic monoclonal antibody 56 immunotoxin 56 HSP# inhibitor 56 Cetuximab 56 TroVax ® 56 IMGN# 56 synthetic peptide 56 Curaxin 56 anticancer agent 56 LHRH agonists 56 targeted radiotherapeutic 56 mapatumumab 56 Panzem R NCD 56 BRAF inhibitors 55 Reolysin 55 MAXY G# 55 Goserelin 55 kinase inhibitors 55 EndoTAG TM -1 55 Tarvacin TM 55 antisense drug 55 adecatumumab 55 uric acid lowering 55 Allovectin 7 R 55 Oxaliplatin 55 JAK3 55 taxol 55 anticancer therapeutics 55 cytotoxic agents 55 vidofludimus 55 AQ4N 55 NEUGENE 55 Tarceva erlotinib 55 OHR/AVR# 55 Fludara 55 dasatinib 55 beta interferons 55 dasatinib Sprycel ® 55 Lapatinib 55 Carboplatin 55 ipilimumab 55 Gleevec 55 BAY #-# 55 Cytarabine 55 Taxotere 55 protein kinase inhibitors 55 renin inhibitors 55 AEG# 55 Dapagliflozin 55 Rituxan rituximab 55 cidofovir 55 visilizumab 55 anti angiogenic drugs 55 antitumoral 55 Leukine 55 GM CSF 55 Campath alemtuzumab 55 IFN alpha 55 topotecan 55 monoclonal 55 HuLuc# 55 BiTE antibody 55 PXD# 55 Litx 55 siRNA therapeutic 55 depsipeptide 55 histone deacetylase inhibitors 55 TPI ASM8 55 HGS# 55 OvaRex ® MAb 55 cabazitaxel 55 NPC 1C 55 immatics 55 Paclitaxel 55 Protectan CBLB# 55 panitumumab 55 cancer therapeutics 55 Genentech Herceptin 55 photodynamic therapy 55 AMN# [001] 55 tigecycline 55 Hycamtin 55 Gleevec imatinib 55 vinca alkaloid 55 Homspera 55 investigational immunotherapy 55 TLR8 55 CA4P 55 immunological 55 antibody MAb 55 gastrointestinal stromal tumors 55 Degarelix 55 receptor tyrosine kinase inhibitor 55 calcitriol 55 CDDO Im 55 triphendiol 55 LHRH antagonist 55 ESBA# 55 GRN#L 55 lentiviral vector 55 humanised monoclonal antibody 55 radioimmunotherapy 55 indibulin 55 vaccines 55 tranilast 55 PARP inhibitor 55 ToleroMune 55 exon skipping 55 otelixizumab 55 docetaxel chemotherapy 55 SCCHN 55 pertuzumab 55 L asparaginase 55 HGS ETR1 55 trabectedin 55 Temsirolimus 55 Doxil ® 55 antibody therapies 55 kinase inhibitor 55 intravenous immunoglobulin 55 gemcitabine Gemzar ® 55 DCVax ® Brain 55 ASONEP 55 ragweed allergy 55 RNAi 55 antitumor 55 adalimumab Humira 55 mertansine 55 talabostat 55 REOLYSIN ® 55 nitazoxanide 55 subcutaneous formulation 55 Pertuzumab 55 Olaparib 55 OMP #M# 55 treatments 55 JAK inhibitor 54 OvaRex R 54 eflornithine 54 myelofibrosis polycythemia vera 54 antigens 54 immunomodulatory therapy 54 tumor antigen 54 recurrent ovarian cancer 54 Fingolimod 54 immunological diseases 54 Fludarabine 54 DepoVax TM 54 interferon beta 54 Docetaxel 54 phase IIb clinical 54 DFMO 54 interferon therapy 54 novel immunotherapeutic 54 Symadex 54 docetaxel Taxotere 54 immunotherapy treatments 54 gastrointestinal stromal tumors GIST 54 prodrugs 54 PEG SN# 54 ALN PCS 54 recombinant 54 DepoVax ™ 54 mAb 54 CCX# 54 Personalized Immunotherapy 54 metastatic renal cell carcinoma 54 VALSTAR 54 preclinical studies 54 molecularly targeted therapies 54 sunitinib 54 gastrin 54 small molecule inhibitors 54 zalutumumab 54 anti TNFs 54 MAbs 54 Onco TCS 54 Yervoy 54 Pazopanib 54 Japanese Encephalitis vaccine 54 Cabazitaxel 54 Taxol 54 pegylated 54 Valortim 54 erlotinib Tarceva ® 54 ADVEXIN 54 TACE 54 standard chemotherapy regimens 54 HQK 54 Hedgehog pathway 54 imetelstat 54 bispecific antibody 54 recombinant protein 54 EGFR antibodies 54 Xanafide 54 immunosuppressant drug 54 chronic myeloid leukemia CML 54 Revlimid lenalidomide 54 Mitoxantrone 54 Treanda 54 Lodamin 54 AAV2 54 axitinib 54 Bezielle 54 anti angiogenic agents 54 antigen 54 Daclizumab 54 hormonal therapies 54 L BLP# 54 CXCR4 receptor 54 NXL# 54 geldanamycin 54 GnRH agonists 54 interferon IFN 54 Vandetanib 54 Liprotamase 54 miglustat 54 teriparatide 54 gemcitabine Gemzar 54 angiogenesis inhibition 54 Alferon N 54 Herceptin trastuzumab 54 paclitaxel Taxol ® 54 vinorelbine 54 Sudhir Agrawal D.Phil 54 adoptive immunotherapy 54 TG# [003] 54 T DM1 54 targeting CD# 54 HuMax CD# 54 neuraminidase inhibitor 54 Abiraterone acetate 54 preclinical 54 efficacious treatments 54 Hsp# inhibitor 54 MGd 54 luteinizing hormone releasing 54 Oncaspar 54 IGF 1R inhibitor 54 PSMA ADC 54 Genasense ® 54 dexamethasone Decadron 54 chemical entities NCEs 54 topical cream 54 Th2 cells 54 follicular non 54 anti angiogenesis 54 antituberculosis 54 pentamidine 54 calcineurin inhibitors 54 selective inhibition 54 pegylation 54 xenograft models 54 therapeutic modalities 54 Micromet BiTE 54 Vorinostat 54 anti angiogenic 54 Omacetaxine 54 biologic 54 belinostat 54 Diamyd ® 54 Sunitinib 54 MyVax 54 GV# [001] 54 Taxotere ® 54 imatinib Gleevec ® 54 chemoradiotherapy 54 investigational drug 54 Cytolin R 54 CR# vcMMAE 54 Azacitidine 54 Zybrestat 54 chimeric monoclonal antibody 54 humanized monoclonal antibodies 54 chemotherapeutic drugs 54 prodrug 54 Xeloda capecitabine 54 Enzastaurin 54 PEGPH# 54 PANVAC VF 54 adenovirus vector 54 multiple myeloma MM 54 stem cell transplantation 54 #ME# 54 STELARA ™ 54 Erlotinib 54 XmAb# 54 ChronVac C ® 54 IGF 1R 54 Seliciclib 54 pan HDAC inhibitor 54 imiquimod 54 ATL# [001] 54 Mipomersen 54 PNP inhibitor 54 polyclonal antibody 54 anakinra 54 adjuvant therapy 54 ELACYT 54 NP2 Enkephalin 54 ROTARIX 54 CoFactor 54 Taxotere docetaxel 54 recurrent metastatic 54 paclitaxel 54 TNF inhibitor 54 RNAi therapeutics 54 anti CD# antibody 54 rapamycin 54 mRCC 54 liposomal formulation 53 trastuzumab 53 Fludara ® 53 SCH # 53 pancreatic neuroendocrine tumors 53 TLR Therapeutics 53 humanized monoclonal antibody 53 antibody fragment 53 MVA BN R 53 ganciclovir 53 allergen immunotherapy 53 DOS# 53 alefacept 53 Archexin 53 SLIT 53 lenalidomide Revlimid R 53 Targretin 53 vaccines oncolytic virus 53 autologous transplant 53 SERMs 53 TroVax 53 Inhaled nitric oxide 53 Amplimexon 53 anti VEGF 53 immune modulators 53 Kevetrin ™ 53 SNT MC# 53 epothilones 53 anti idiotype 53 PEGylated interferon 53 systemic RNAi therapeutic 53 velafermin 53 fluticasone furoate 53 chronic lymphocytic leukemia CLL 53 tocilizumab 53 Bendamustine 53 radiation sensitizer 53 TNF alpha inhibitors 53 EGF receptor 53 Interferon alfa 53 sapacitabine 53 EndoTAG TM 53 MyVax ® 53 Virulizin ® 53 ALN TTR# 53 dacarbazine 53 mTOR inhibitor 53 chemotherapy docetaxel 53 inhaled antibiotic 53 pegylated liposomal doxorubicin 53 HyperAcute 53 TLR agonists 53 liprotamase 53 masitinib 53 HspE7 53 Sphingomab 53 topical formulations 53 vandetanib 53 FluCide 53 tumor antigens 53 rolapitant 53 clinical trials 53 MUC1 53 autoimmune 53 RPL# 53 Ixempra 53 etanercept Enbrel 53 Privigen 53 humanized monoclonal 53 Laquinimod 53 factor TNF 53 metastatic colorectal 53 interferons 53 A3 adenosine receptor 53 integrase inhibitor 53 echinocandin 53 antiviral compounds 53 preclinically 53 predictive biomarkers 53 Enzyme Replacement Therapy 53 Neulasta ® 53 live attenuated vaccines 53 antisense oligonucleotide 53 anti angiogenic therapy 53 gefitinib Iressa 53 cellular immunotherapy 53 neutralizing antibodies 53 RNAi therapeutic targeting 53 flavopiridol 53 post herpetic neuralgia 53 anti CD3 53 Ampligen 53 topical gel 53 sorafenib 53 Aliskiren 53 protein therapeutics 53 AKT inhibitor 53 Pradefovir 53 Synavive 53 MLN# 53 enzyme inhibitor 53 immuno oncology 53 EFAPROXYN 53 Regado 53 Vivaglobin 53 JVRS 53 Rasagiline 53 Bevacizumab 53 PEGylation technology 53 interferon alpha 2b 53 hematologic malignancies 53 Erbitux 53 Talabostat 53 Valortim R 53 PLX# 53 antiemetic 53 bioscavenger 53 p# inhibitor 53 HuMax EGFr 53 synthetic retinoid 53 AMPK activators 53 ProSavin 53 Abraxane 53 LEAPS TM 53 Eliezer Zomer Ph.D. 53 VZV 53 chemotherapy regimens 53 GammaCan 53 gamma secretase inhibitors 53 Revlimid 53 oncology 53 interferon alfa 53 TRV# [001] 53 Cyclosporine 53 taxane 53 mycophenolate mofetil 53 Th2 cytokines 53 Caelyx 53 IAP inhibitor 53 Novartis Gleevec 53 intratumoral injection 53 histone deacetylase HDAC inhibitor 53 LHRH 53 iPSC 53 DiLA2 53 nanoemulsion 53 antiviral therapeutics 53 Neugene 53 TNF alpha inhibitor 53 oncology therapeutics 53 Cloretazine VNP#M 53 cytotoxic 53 denileukin diftitox 53 NeuroVax TM 53 SinuNase 53 Bendavia 53 adalimumab 53 aminoglycoside 53 MabThera rituximab 53 pazopanib 53 bexarotene 53 LHRH antagonists 53 kidney urologic 53 picoplatin 53 epithelial tumors 53 treatment regimens 53 anti infective treatments 53 cetuximab Erbitux R 53 Crizotinib 53 LHRH agonist 53 daptomycin 53 relapsed leukemia 53 electroporation 53 Nexavar sorafenib 53 Vaxfectin TM 53 Monoclonal antibody 53 lymphomas 53 ChronVac C R 53 cediranib 53 S/GSK# 53 MMP inhibitors 53 standard chemotherapy regimen 53 Sapacitabine 53 infliximab Remicade 53 MVA BN 53 Rebif ® 53 IGIV 53 FOLFIRINOX 53 metastatic colon cancer 53 docetaxel Taxotere ® 53 Viprinex 53 TNF inhibitors 53 recombinant vaccines 53 chemotherapy 53 5FU 53 TACI Ig 53 immune suppression 53 solid tumors 53 vaccine adjuvant 53 orally bioavailable 53 palliative radiotherapy 53 chemopreventive agents 53 Ontak 53 RAV# 53 Valortim ® 53 TLR9 agonists 53 Enkephalin 53 hedgehog pathway 53 tremelimumab 53 Hsp# inhibition 53 Phase IIb clinical trials 53 FOLFOX chemotherapy 53 Neuvenge 53 adenoviral 53 Pralatrexate 53 idraparinux 53 neural stem cell 53 amrubicin 53 oral anticoagulants 53 direct thrombin inhibitors 53 Glivec imatinib 53 dasatinib Sprycel 53 immunosuppressive regimens 53 macrolide antibiotics 53 theranostic 53 Zytiga 53 antigen sparing 53 Aflibercept 53 BHT DNA 53 omalizumab 53 radiolabeled antibodies 53 veltuzumab 53 mda 7 53 Interferon beta 53 Rilutek 53 therapeutic peptide 53 Bortezomib 53 Cerashield 53 GRASPA ® 53 canakinumab 53 GAP #B# 53 Anticalins 53 cisplatin 53 fenretinide 53 Abatacept 53 Velcade 53 Tamibarotene 53 H#N# antigen 53 antimetabolite 53 Kevetrin 53 cytotoxics 53 CCR5 antagonist 53 regenerative medicine therapies 53 basiliximab 53 adjuvants 53 Orazol 53 antiangiogenic agents 53 busulfan 53 EGFR tyrosine kinase inhibitors 53 immunosuppression 53 anti infective 53 Vicinium TM 53 meropenem 53 liver metastases 53 trivalent influenza vaccine 53 Noxafil 53 leukemia AML 53 DepoVax 53 thymalfasin 52 AP# [003] 52 chemotherapy induced neutropenia 52 chemopreventive agent 52 LEUKINE 52 biosurgical 52 androgen receptor antagonist 52 lapatinib 52 metastatic melanoma 52 pancreatic NET 52 malignant pleural mesothelioma 52 fluorouracil 52 reslizumab 52 EGFr 52 Imatinib 52 HCD# [002] 52 immunotherapeutic approaches 52 recombinant interferon 52 Cardio Vascu Grow 52 Decitabine 52 plasmid DNA vaccine 52 Phase Ib 52 biomarker 52 allogeneic cell 52 Pegasys ® 52 aptamers 52 insulin analogues 52 CDP# 52 Factor Xa inhibitor 52 Blinatumomab 52 nucleoside analog 52 AmpliMed 52 KineMed 52 cytoreduction 52 Telintra 52 antisense compounds 52 transdermal delivery 52 idarubicin 52 paclitaxel Taxol R 52 rilonacept 52 lenalidomide dexamethasone 52 indolent NHL 52 FVIIa 52 anticancer treatments 52 elacytarabine 52 MAGE A3 ASCI 52 PLX cells 52 biologic therapeutics 52 Clavis Pharma 52 CTLA 4 52 huC# DM4 52 novel anticancer 52 IMC A# 52 trastuzumab Herceptin ® 52 TAFA# 52 relapsed CLL 52 HCV protease inhibitors 52 Cylene 52 relapsing multiple sclerosis 52 Neuradiab 52 drug conjugate 52 Satraplatin 52 incyclinide 52 Photodynamic therapy 52 MabThera 52 carboplatin 52 Multikine 52 Dendreon Provenge 52 irinotecan chemotherapy 52 JAK2 inhibitors 52 Theratope 52 tesmilifene 52 rBChE 52 Bacillus Calmette Guerin BCG 52 Onalta ™ 52 Pegylated Interferon 52 subcutaneously administered 52 PORxin TM 52 antisense drugs 52 rituximab Rituxan ® 52 Adjuvant chemotherapy 52 neuroendocrine cancers 52 ketolide antibiotic 52 oral prodrug 52 administered subcutaneously 52 PCK# 52 metastatic RCC 52 lumiliximab 52 ONTAK 52 Mpex 52 HDAC inhibitors 52 Ebola vaccine 52 photodisinfection 52 stem cell therapy 52 etanercept 52 teplizumab 52 Voreloxin 52 Fodosine 52 immunologic 52 EGFR inhibitors 52 Kepivance 52 biotherapies 52 Tesetaxel 52 glioblastoma multiforme GBM 52 OvaRex 52 monoclonal anti 52 Phase Ib II 52 vemurafenib 52 chemotherapeutic regimen 52 prostone 52 Annamycin 52 Hsp# inhibitors 52 targeted biologic therapies 52 atrasentan 52 tolevamer 52 VIDAZA 52 CDK inhibitor 52 cytotoxic chemotherapy 52 cytostatic 52 photosensitizer 52 ara C 52 Epratuzumab 52 CD# monoclonal antibody 52 Celator 52 ceftriaxone 52 adefovir dipivoxil 52 Combination therapy 52 NF kB pathway 52 intranasal vaccine 52 ENMD # 52 bone marrow transplantation 52 novel immunotherapies 52 deacetylase inhibitors 52 anidulafungin 52 radiotherapeutic 52 Hedgehog inhibitor 52 Excellarate 52 relapsed multiple myeloma 52 Bioral 52 Onalta 52 tyrosine kinase inhibitor TKI 52 anti leukemic 52 voreloxin 52 CYT# 52 AZD# 52 fulvestrant 52 multiple myeloma 52 sipuleucel T 52 Ribavirin 52 ONCASPAR 52 XmAb 52 immune modulator 52 Vidofludimus 52 SCIg 52 custirsen 52 polymerase inhibitors 52 resolvins 52 recombinant subunit vaccine 52 Angiocept 52 NNRTIs 52 acyclovir Lauriad R 52 Homspera TM 52 HBV vaccine 52 gamma secretase inhibitor 52 granisetron 52 Arcalyst 52 Pegasys peginterferon alfa 2a 52 Quinamed 52 isavuconazole 52 FTY# 52 hyperthermia therapy 52 Panzem R 52 antitumor effect 52 LEX System 52 metastatic kidney 52 Mycograb 52 Bexxar 52 CCR5 inhibitor